Cytoarchitectural abnormalities have been described in the prefrontal cortex of subjects with schizophrenia, bipolar disorder and depression. However, little is known about the gene expression profiles associated with these abnormalities. Genome-wide expression profiling technology provides an unbiased approach to identifying candidate genes and biological processes that may be associated with complex biological traits such as cytoarchitecture. In this study, we explored expression profiles associated with the abnormalities by using publicly available microarray metadata and cytoarchitectural data from post-mortem samples of the frontal cortex from 54 subjects (schizophrenia, n = 14; bipolar disorder, n = 13; depression, n = 12 and controls n = 15). Correlation analysis between genome-wide expression levels and cytoarchitectural traits revealed that 818 genes were significantly correlated with a decrease in the number of perineuronal oligodendrocytes across all subjects. A total of 600 genes were significantly correlated with a decrease in density of calbindin-positive interneurons across all subjects. Multiple biological processes including cellular metabolism, central nervous system development, cell motility and programmed cell death were significantly overrepresented in both correlated gene lists. These findings may provide novel insights into the molecular mechanisms that underlie the cytoarchitectural abnormalities of perineuronal oligodendrocytes and calbindin-containing GABAergic interneurons in the prefrontal cortex of the major psychiatric disorders.
Introduction
Many cytoarchitectural abnormalities have been described in the prefrontal cortex (PFC) of the major psychiatric disorders, schizophrenia, 1 bipolar disorder 2 and depression. 3 Neuropathological studies have revealed reduced density of oligodendrocytes, 4 reduced numbers of oligodendrocytes associated with a pyramidal neuron, 5 decreased cell size of pyramidal neurons 5 and reduced cell density of g-aminobutyric acid (GABA)ergic interneurons 6 in the PFC. Although neurodevelopmental deficits and apoptosis may contribute to these cytoarchitectural abnormalities, the molecular mechanisms that underlie them remain to be determined.
Gene expression profiles, produced by microarray technology, provide an unbiased approach to identify the possible molecular mechanisms that underlie complex biological traits such as behavior, aging and psychiatric disorders. [7] [8] [9] Public databases that contain microarray data and biological traits from the same samples provide researchers with an opportunity to explore molecular mechanisms without timeconsuming and labor-intensive benchwork. 10, 11 The Stanley Medical Research Institute database (SMRIDB; http://www.stanleyresearch.org/brain/) includes microarray data from multiple independent studies 12 and various cytoarchitectural data sets from several brain regions of the same patients. [13] [14] [15] [16] The cytoarchitectural data were generated by many independent investigators using samples from the Stanley neuropathology consortium (SNC), which contains 15 well-matched cases in each of four groups: schizophrenia, bipolar disorder, major depression and unaffected controls. These groups are matched for descriptive variables such as age, gender, race, post-mortem interval (PMI), mRNA quality, brain pH and hemisphere. The SMRIDB also contains whole genome expression data from 12 independent microarray studies. 12 Three of these studies used PFC samples from the SNC. In this study we explored genes and biological processes associated with the cytoarchitectural abnormalities in the PFC of major psychiatric disorders by using microarray metadata and cytoarchitectural data downloaded from the SMRIDB.
Materials and methods

Brain samples and cytoarchitectural traits
The brain samples included in the SNC were collected by pathologists in the Office of the Medical Examiner in several states with the families' permission. 17 A detailed description of the selection process, clinical information, diagnoses of patients and processing of tissues has been described previously. 17 The cytoarchitectural traits such as cell density and cell size from PFC (Brodmann's area 8, 9, 10 and 46) were downloaded from the SMRIDB (http:// www.stanleyresearch.org/brain/). Only data sets with continuous variables were included and then only if more than 90% of the cases (nX54) were available. A summary of the traits included in this study are listed in Table 1 . The raw data and more detailed study information are also available from the database (http://www.stanleyresearch.org/brain/).
Nonparametric variance analysis
The effect of the disorders on the cytoarchitectural traits was initially tested by variance analysis. The nonparametric Kruskal-Wallis test was used because not all of the traits are normally distributed. If there was a significant effect of the disorders on a trait (P < 0.05), a post hoc Mann-Whitney U-test for group differences between each disorder group and unaffected controls was used (StatView, SAS, Cary, NC, USA). It should be noted that because we analyzed all available data sets by nonparametric statistical methods without preprocessing, our results may not be consistent with the previously published analyses of these data.
Microarray data
Microarray Suite version 5.0 (MAS5)-normalized microarray data from two independent studies were downloaded from the SMRIDB and used for microarray analysis. Only microarray data using the Affymetrix chips were used, to avoid variations from different platforms. The Affymetrix Human Genome U133 Set A containing 22 215 probe sets was used in one study, and the Affymetrix Human Genome 95av2 containing 12 453 probe sets was used in the other study. Outlier chips were excluded in this analysis based on previous quality control analyses. 12 A total of 21 chips from 13 bipolar patients, 16 chips from 12 depression patients, 20 chips from 14 schizophrenia patients and 21 chips from 15 unaffected controls were used here. Duplicate microarray data sets were treated as technical replicates.
Correlation analysis of cytoarchitectural traits and microarray data Microarray data from the independent studies were initially converted to Entrez Gene ID for further metaanalysis. Further data preprocessing and correlation analysis were conducted using the biometric research branch (BRB)-array tools (http://linus.nci.nih.gov/ BRB-ArrayTools.html). Low-expression genes were filtered out using the intensity filter if the expression level of a gene was below 10. After median normalization, potential noninformative genes were screened by the default gene filters, as previously described. 18, 19 Genes were filtered out if less than 20% of their expression values across the samples showed at least a 1.5-fold change in either direction from the gene's median value or if the variance of the log ratios for each gene was less variable than the median of all the variances (P > 0.01). A total of 3572 genes passed this filtering step. The correlation between the filtered genes and the selected cytoarchitectural traits were tested by Spearman's rank correlation analysis. The significance level was set at a false discovery rate (FDR) of 0.2, 20 which is reasonably robust as an exploratory microarray study for differential expression analysis 21, 22 as well as correlation analysis. 23 Moreover, the functional annotation may increase the robustness by providing evidence of significant overrepresentation of a group of genes from the same biological process. [23] [24] [25] Correlation analysis between protein levels and cytoarchitectural traits Protein levels of protein kinase B (Akt), neuronspecific enolase (ENO2), cyclin-dependent kinase 5 (CDK5), glial fibrillary acidic protein (GFAP), 
Covariance
Potential confounding factors were identified by multiple statistical methods as previously described but with slight modifications. 11 First, we tested if there were statistical differences in the variables between the diagnostic groups. The continuous variables (such as age, brain pH, PMI and duration of formalin storage) were examined by nonparametric variance analysis (StatView). Two variables (lifetime exposure to antipsychotics and duration of illness) were omitted, as these are only disorder-specific variables. The categorical variables (such as sex, rate of death, smoking, alcohol and drug abuse) were tested using w 2 -tests of association (StatView). P-values less than 0.05 were considered significant.
Second, we tested if there were associations between any of the 11 descriptive variables and the cytoarchitectural traits. The effects of the continuous variables on the cytoarchitectural traits were examined by Spearman's rank correlation (StatView) . The categorical variables were tested by nonparametric variance analysis (StatView). P-values less than 0.05 were considered significant. In addition, forward stepwise multiple regression analyses were conducted with all the variables to examine the associations of those with the cytoarchitectural traits (StatView). 26, 27 Each variable was included in a model if its partial F-ratio was above 4.
Finally, correlations between the descriptive variables and the expression levels of the filtered genes (n = 3572) were tested using the BRB-array tools. The continuous variables were tested by Spearman's rank correlation, and the categorical variables were tested by variance analysis. FDR adjusted P-values less than 0.2 were considered significant. We considered a descriptive variable as a significant confounding factor if a variable showed significant association with the cytoarchitectural trait as well as significant correlation with more than 50 genes.
Functional annotation
The significantly correlated genes were functionally annotated using the database for annotation, visualization and integrated discovery integrated database query tool (http://david.abcc.ncifcrf.gov/) and by the overrepresentational analysis method. 28 The biological processes of Gene Ontology Consortium (http:// www.geneontology.org) at level 4 were used for functional annotations. P-values less than 0.05 were considered significant.
Results
Variance analysis of prefrontal cytoarchitectural traits
The variance analysis was conducted to examine the effect of psychiatric disorder on cytoarchitectural traits in the PFC. There was a significant effect of disorder on five prefrontal cytoarchitectural traits (P < 0.05). Four of those traits showed significant differences between at least one disorder group and the unaffected controls by the post hoc MannWhitney U-test. The results of the variance analysis are summarized in Table 2 . Two oligodendrocyterelated traits from layers III and VI of BA9 were significantly different between each of the three psychiatric disorder groups and the unaffected controls. The size of pyramidal neurons in layer III of BA9 was significantly reduced in the bipolar disorder group compared with the unaffected controls. The density of calbindin-positive neurons in BA9 also showed a significant difference between all three disorder groups and the unaffected controls. Genes associated with oligodendrocyte-related abnormalities in psychiatric disorders A correlation analysis was performed with microarray metadata from the same brain region of the same patient samples to identify genes associated with the cytoarchitectural abnormalities. Table 3 summarizes the total number of genes correlated with the cytoarchitectural traits. The expression levels of 818 genes were significantly correlated with the number of perineuronal oligodendrocytes in layer III of BA9 across all 54 subjects. The gene symbols, titles and Entrez ID of the 818 genes, correlation coefficients and corresponding P-values are listed in Supplementary Table 1 Although there were no genes that showed a significant correlation between expression level and oligodendrocyte density in layer VI of BA9 across all 54 subjects, there were 790 genes that showed a significant correlation between these traits in just the bipolar disorder and unaffected control subjects (n = 28; Supplementary Table 2) .
Genes associated with reduction of calbindincontaining neuronal density in psychiatric disorders Correlation analysis revealed that the expression levels of 600 genes were significantly correlated with the density of calbindin-positive GABAergic interneurons in the PFC (BA9) across all subjects (Supplementary Table 3 ). As would be predicted, the expression level of the gene coding for the marker used in the immunostaining, CALB1 (calbindin 1), was positively correlated with the density of the calbindin-positive neurons (r = 0.3, P = 0.03), as were several other genes associated with the GABAergic interneurons (e.g., neuropeptide Y, somatostatin and cholycystokinin). Biological processes overrepresented in the correlated genes Functional annotation of the significantly correlated genes with the perineuronal oligodendrocytes by Gene Ontology indicated that 41 biological processes were significantly overrepresented (at level 4; P < 0.05; Table 4 ). Cellular biosynthesis, protein localization, biosynthesis and catabolism, several cellular metabolism processes, central nervous system development, neurogenesis, cell motility and regulation of programmed cell death processes were all included.
A total of 35 biological processes, such as several transport-related processes, cell motility, central nervous system development, programmed cell death and cellular morphogenesis, were significantly overrepresented in the genes correlated with the density of calbindin-positive neurons (at level 4, P = 0.05; Table 5 ). Transport was the most significant process identified in the gene lists (P = 1.77EÀ08). Five GABA receptor genes were included in this process: Gabra1 (GABA A receptor, a1), Gabra2 (GABA A receptor, a2), Gabra5 (GABA A receptor, a5), GABRG2 (GABA A receptor, g2) and GABRD (GABA A receptor, d). The vesicle-mediated transport genes were also highly significantly overrepresented in the biological processes gene list (P = 2.30EÀ08) and included several well-known genes encoding presynaptic proteins, such as SYT1 (synaptotagmin I), STXBP1 (syntaxin binding protein 1), SNAP25 (synaptosomal-associated protein, 25 kDa) and STX1A (syntaxin 1A) (Supplementary Table 4 ).
Correlations between protein levels and cytoarchitectural traits Protein levels were available for six genes listed among the 818 genes with mRNA levels significantly correlated with the number of perineuronal oligodendrocytes. Associations of those protein levels with the cytoarchitectural abnormality were tested by correlation analysis. Akt protein levels were significantly correlated with the trait (r = 0.301, P = 0.02). Protein levels of CDK5, ENO2, GFAP, HRAS and MAPK3 did not show any significant correlations with the trait. Protein expression data were available for four genes listed among the 600 genes significantly correlated with the density of calbindin-positive neurons. Akt and CDK5 protein levels were significantly correlated with the trait (both P = 0.02), whereas ENO2 and MAPK1 protein levels were not.
Potential confounding factors
Potential confounding variables were tested by multiple statistical methods. First, analysis of variance or the w 2 -tests were used to determine if the 11 descriptive variables differed between the diagnostic groups (Table 6 ). Only the formalin storage times of the tissue samples were significantly different between the groups (P = 0.02). Second, associations between the descriptive variables and the cytoarchitectural traits were tested by correlation analysis or variance analysis (Table 6 ). Duration of formalin storage (P = 0.002), lifetime exposure to antipsychotics (P < 0.0001), and duration of illness (P < 0.0001) Figure 1 Correlation between expression levels of succinate-CoA ligase, ADP-forming, b subunit (SUCLA2) and TGF-binduced apoptosis protein 2 (TAIP-2) and number of perineuronal oligodendrocytes in prefrontal cortex of all subjects in the Stanley neuropathology consortium (SNC) and box plots of the trait and expression levels for each diagnostic group. The expression level of SUCLA2 was positively correlated with the number of perineuronal oligodendrocytes (r = 0.669, P = 3.40EÀ06, a). The expression level of TAIP-2 was negatively correlated with the number of perineuronal oligodendrocytes (r = À0.563, P = 0.00016, b). Box plots show the median and distribution of perineuronal oligodendrocyte number (c), expression level of SUCLA2 (d) and expression level of TAIP-2 (e) for each group; K, bipolar disorder; J, depression; ., schizophrenia and &, normal control.
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were significantly associated with perineuronal oligodendrocytes. In contrast, brain pH and duration of illness were significantly correlated with the density of calbindin-positive neurons (P = 0.01 for both) as well as the oligodendrocyte density in layer VI of BA9 (P = 0.01 and 0.04, respectively). There was no descriptive variable significantly associated with all the cytoarchitectural traits. Finally, the correlation analysis between the descriptive variables and the informative microarray data (n = 3572) revealed that expression levels of more than 50 genes were associated with PMI (n = 598) or duration of illness (n = 162) ( Table 6 ).
Associations of the descriptive variables with the cytoarchitectural traits were further tested by an independent statistical method (Supplementary Table 5 ).
Stepwise multiple regression analyses indicated that age of the patient, illicit drug abuse, smoking and duration of illness were significantly associated with perineuronal oligodendrocytes. Only brain pH was significantly correlated with the density of calbindinpositive neurons. However, taken together, the results indicate that duration of illness was the only variable that was significantly associated with the two oligodendrocyte-related traits as well as significantly correlated with more than 50 genes. Therefore, Figure 2 Correlation between expression levels of secretory carrier membrane protein 1 (SCAMP1) and nuclear receptor subfamily 5, group A, member 2 (NR5A1) and density of calbindin-containing neurons in prefrontal cortex of all subjects in the Stanley neuropathology consortium (SNC) and box plots of the trait and expression levels for each diagnostic group. The expression level of SCAMP1 was positively correlated with the density of calbindin-containing neurons (r = 0.499, P = 0.0001518, a), whereas the expression level of NR5A1 was negatively correlated with the density of calbindin-containing neurons (r = À0.515, P = 8.62EÀ05, b). Box plots show the median and distribution of the density of calbinding-containing neurons (c), expression level of SCAMP1 (d) and expression level of NR5A1 (e) in each group; K, bipolar disorder; J, depression; ., schizophrenia and &, normal control.
duration of illness appears to be the most significant potential confounding variable of the two oligodendrocyte-related cytoarchitectural abnormalities.
Discussion
Correlation analysis between genome-wide expression profiles and complex traits has yielded useful information for pathogenic mechanisms that underlie Alzheimer's disease in humans 23 as well as for the regulatory networks that underlie liver metabolism in a mouse model. 29, 30 We employed the approach to identify genes and biological processes that are associated with cytoarchitectural abnormalities found in the PFC of major psychiatric disorders. Our functional annotation analysis revealed that multiple biological processes including cell metabolism, neurodevelopment, cell motility and programmed cell death were commonly associated with the prefrontal cytoarchitectural deficits of perineuronal oligodendrocytes (Table 4 ) and calbindin-positive GABAergic neurons (Table 5 ). There were no genes significantly associated with antipsychotic treatment (Table 6 ). Moreover, recent primate studies indicated that there were no effects of antipsychotic treatment on the density of oligodendrocytes 31 or the expression of a GABAergic markers in the PFC neurons. 32 Hence, the cytoarchitectural abnormalities in the PFC of psychiatric disorders may be attributable to the differential expression of genes associated with biological Expression profiles for cytoarchitectural deficits S Kim and MJ Webster processes such as apoptosis and/or neurodevelopment. The cytoarchitectural traits related to oligodendrocytes that were used in this study were originally reported by Dr Natalya Uranova and colleagues. 4, 5 They identified a significant reduction of perineuronal oligodendrocytes in layer III of BA9 5 in all three psychiatric disorders as well as a decrease in the density of oligodendrocytes in layer VI of BA9. 4 Our correlation analysis revealed that 818 genes were significantly associated with the number of perineuronal oligodendrocytes in the frontal cortex of all subjects in the SNC (Supplementary Table 1 ). Three oligodendrocyte markers positively correlated with the number of perineuronal oligodendrocytes: myelin oligodendrocyte glycoprotein (MOG), oligodendrocyte myelin glycoprotein (OMG) and proteolipid protein 1 (PLP1). These correlations directly reflect the reduction in the number of perineuronal oligodendrocytes. Cellular metabolism processes, including those related to mitochondrial genes, were highly overrepresented in our gene lists. Previous studies have described global changes in expression levels of mitochondrial genes and proteins in schizophrenia and bipolar disorder. 33, 34 However, we found that mitochondria-related biological processes were significantly associated with duration of illness (Supplementary Tables 6 and 7) and that duration of illness was the most significant confounding factor for oligodendrocyte-related traits. Thus, abnormalities in the metabolic processes are more likely to be a consequence of the illness than a cause of the perineuronal oligodendrocyte abnormality.
Apoptosis has been proposed as a possible mechanism that may underlie some of the cytoarchitectural abnormalities seen in schizophrenia and bipolar disorder. 35 Histological signs of apoptosis and necrosis of oligodendrocytes have been reported in the PFC of schizophrenia and bipolar disorder cases from a cohort independent from the one used in this study. 36 Our correlation analysis revealed that programmed cell death was significantly associated with the Table 3 ) and Akt protein levels were also significantly correlated with the number of perineuronal oligodendrocytes (r = 0.301, P = 0.02) and with the density of calbindinpositive neurons (r = 0.30, P = 0.02) across all subjects (n = 60). The phosphatidylinositl 3-kinase (PI3K)-Akt signaling pathway inhibits programmed cell death by responding to neurotrophic factors in the brain. Deficits in this process have been proposed as a potential mechanism that may contribute to the neuronal cell death observed in mood disorders. 37 Taken together, these findings imply that multiple apoptotic pathways that involve the PI3K-Akt signaling pathway may cooperatively contribute to the reduction of the perineuronal oligodendrocytes and of the calbindin-positive GABAergic neurons in the psychiatric disorders. Correlation analyses between genome-wide expression data and cytoarchitectural traits were conducted for all subjects combined as well as for each individual diagnostic group with the unaffected controls, to examine the possible disorder-specific associations of gene expression profiles. The most significant correlations were found in the cytoarchitectural traits from bipolar disorder and unaffected controls. For example, there were no genes significantly correlated with oligodendrocyte density in layer VI of BA9 across all the samples from the four diagnostic groups (n = 54); however, there were 790 genes correlated with this trait for the bipolar disorder and unaffected control subjects (n = 28). This indicates that the association of the genome-wide expression levels with this particular cytoarchitectural abnormality may be more predominant in the subjects with bipolar disorder than in those with depression or schizophrenia. Increasing the sample size with additional samples that have low effect (e.g., the depression and schizophrenia samples) would dilute the overall significant level of the correlations for the combined samples. It is notable that all the cytoarchitectural traits were more significantly decreased in the bipolar disorder group as compared with the other two groups and as compared with the unaffected controls; thus, it is not surprising that more genes would show a significant correlation with trait in the bipolar and control samples. Nevertheless, genomewide microarray studies with relatively small sample sizes are prone to yielding results with low statistical power; 38 therefore, a larger sample size will be required to obtain replicable results for disorderspecific correlations.
Although this study provides many interesting avenues for further exploration and data mining, it should be viewed as exploratory at this stage. Moreover, it has several limitations. First, although the brain samples are from the same brain region and from the same patients, the cytoarchitectural markers are cell type specific, whereas the microarray data are from tissue extracts with mixed cell types. The mixed cellular nature of the samples used in the microarray studies may dilute the effects of specific cell populations in specific cortical layers. 39 Hence, future celltype-specific microarray data using laser capture microdissection will increase the sensitivity and specificity of studies designed to identify genes associated with the cytoarchitectural abnormalities in psychiatric disorders. Second, although all the available descriptive variables were tested by multiple statistical methods to identify potential confounding factors, we cannot exclude the possibility that unobserved variables might significantly affect correlation between the cytoarchitectural traits and the expression profiles. Our findings are correlational associations, which include both causation and consequences. However, the candidate genes that can be identified from the biological processes associated with the cytoarchitectural abnormalities may provide entry points for future studies. These types of studies may eventually lead to the identification of the genes causing the cytoarchitectural traits that are deficient in the psychiatric disorders.
